The use of immunomodulators as an adjunct to antituberculous chemotherapy in non-responsive patients with osteo-articular tuberculosis

Journal of Bone and Joint Surgery - Series B

Volumn 88, Issue 2, 2006, Pages 264-269

  Arora, Anil ^a,d   Nadkarni, B ^a   Dev, G ^a   Chattopadhya, D ^b   Jain, A K ^a   Tuli, S M ^c   Kumar, S ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF COMMUNICABLE DISEASES   (India)

^c Vidyasagar Institute of Mental Health and Neurosciences Hospital   (India)

^d NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA TETANUS VACCINE; ETHAMBUTOL; IMMUNOMODULATING AGENT; ISONIAZID; LEVAMISOLE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG RESPONSE; DRUG USE; FEMALE; FOLLOW UP; HEALING; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULOUS ARTHRITIS;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; BCG VACCINE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA TOXOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEVAMISOLE; MALE; MIDDLE AGED; TETANUS TOXOID; TREATMENT OUTCOME; TUBERCULOSIS, OSTEOARTICULAR;

EID: 33244475155     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.88B2.17197     Document Type: Article

References (42)

1. Talavera W, Miranda R, Lessnau KKL, Klapholz A. Extrapulmonary tuberculosis. In: Friedman LN, ed. Tuberculosis: current concepts and treatment. Second ed. New York CRC Press, 2001.
2. World Health Organisation. Antituberculosis drug resistance in the world. In: The WHO/UATLD global project on drug resistance surveillance 1994-1997. Geneva: Switzerland, 1997:1-227.
3. Onwubalili JK, Edwards AJ, Palmer L. T4 lymphopenia in human tuberculosis. Tubercle 1987;68:195-200.
4. Beck JS, Potts RC, Kardjito T, Grange JM. T4 lymphopenia in patients with active pulmonary tuberculosis. Clin Exp Immunol 1985;60:49-54.
5. Khomenko AG, Averbach MM, Litvinov VI, Gergert VJ, Chukanov VI. Effect of chemotherapy in the immunological characteristics of patients with primary destructive pulmonary tuberculosis. Bull World Health Organ 1984;62:763-71.
6. Singhal M, Banavalikar JN, Shanna S, Saha K. Peripheral blood T lymphocyte subpopulation in patients with tuberculosis and the effect of chemotherapy. Tubercle 1989;70:171-8.
7. Bose M, Gupta A, Banavalikar JN, Saha K. Dysregulation of homeostasis of blood T lymphocyte subpopulations persists in chronic multibacillary pulmonary tuberculosis patients refractory to treatment. Tuber Lung Dis 1995;76:59-64.
8. Addington WW. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest 1979:76(6 Suppl):741-3.
9. Second East African/British Medical Research Council Report. Controlled clinical trial of four short course (6 months) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1974;1:1100-8.
10. Stanford JL, Bahr GM, Byass P, et al. A modern approach to the immunotherapy of tuberculosis. Bull Int Union Tuberc Lung Dis 1990;65:27-9.
11. Eternadi A, Farid R, Stanford JL. Immunotherapy for drug resistant tuberculosis. Lancet 1992;340:1360-1.
12. Martinez D, Zaias N. Levamisole as an adjunct to dapsone in leprosy. Lancet 1976; 2:209-10.
13. Kazura JW, Hegendank W, Guerry D, Schreiber AD. Human monocyte lymphocyte interaction and its enhancement by levamisole. Clin Exp Immunol 1979;35:258-68.
14. Verhaegen H, De Cree J, De Cock W, Verbruggen F. Restoration by levamisole of low E-rosette forming cells in patients suffering from various diseases. Clin Exp Immunol 1977;27:313-18.
15. Hoft DF, Kemp EB, Marinaro M, et al. A double blind, placebo-controlled study of Mycobaterium-specific human immune responses induced by intradermal bacilli Calmette-Guerin vaccination. J Lab Clin Med 1999;134:244-52.
16. Ishibashi T, Harada S. Takamoto M, et al. Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection. Jpn J Exp Med 1978;48: 35-40.
17. Tuli SM. General principles of osteoarticular tuberculosis. Clin Orthop 2002;398: 11-19.
18. Rohtagi A, Agarwal SK, Bose M, Chattopadhya D, Saha K. Blood bone marrow and splenic lymophocyte subset profiles in Indian Visceri Leishmaniasis. Trans R Soc Trop Med Hyg 1996;90:431-4.
19. Chattopadhya D, Grover SS, Sharma M, Ichhpujani RL, Baveja UK. Immune response in HIV-1 infected children with thalassasmia given a primary course of DPT vaccine before acquiring HIV-1 infection. Ann Trop Paed 2003;23:279-92.
20. Tuli SM. Tuberculosis of the skeletal system. Second ed. New Delhi: Jaypee Brothers Medical Publishers, 1997;47-56.
21. Chaudhury S, Hazra SK, Saha B, et al. An eight year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis. Int J Lepr 1994;62:389-94.
22. Choudhury S, Hazra SK, Mukherjee A, et al. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose convit vaccine as an adjuvant to multi-drug therapy: a six year follow-up study in Calcutta. Int J Lepr 1957;1:56-62.
23. Glassroth J. Diagnosis of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York: Raven Press, 1994; 149-65.
24. Gillespie WJ. Epidemiology in bone and joint infection. Infect Dis Clin North Am 1990;4:361-76.
25. Aggarwal RP, Mohan N, Garg RK, et al. Clinicosocial aspects of osteoarticular tuberculosis. J Indian Med Assoc 1990;88:307-9.
26. Nicholson AR. Twenty years of bone and joint tuberculosis in Bradford: a comparison of the disease in the Indigenous and Asian populations. J Bone Joint Surg [Br] 1974;56-B:760-5.
27. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-12.
28. Somoskovi A, Zissel G, Zipfel PF, et al. Different cytokine patterns correlate with the extension of the disease in pulmonary tuberculosis. Eur Cytokine Netw 1999;10: 135-42.
29. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection. Medicine (Baltimore) 1991;70:384-97.
30. Govender S, Annamalai K, Kumar KPS, Govender UG. Spinal tuberculosis in HIV positive and negative patients: immunological response and clinical outcome. Int Orthop 2000;24:163-6.
31. Youmans GP. Mechanisms of immunity of tuberculosis. Pathobiol Annu 1979;9: 137-62.
32. Cox JH, Ivanyi J. The role of host factors for chemotherapy of BCG infection in inbred strains of mice. Acta Pathol Microbiol Immunol Scand 1988;96:927-32.
33. Moms CD, Bird AR, Nell H. The haematological and biochemical changes in severe tuberculosis. Q J Med 1989;73:1151-9.
34. Chandra RK. Nutrition, immunity and infection: present knowledge and future direction. Lancet 1983;1:688-91.
35. Keet IPM, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993;7:51-7.
36. No authors listed. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725-35.
37. Bahr GM, Shaaban MA, Gabriel M, et al. Improved immunotherapy for pulmonary tuberculosis with Mycobacterium vaccae. Tubercle 1990;71:259-66.
38. Dlugovilzky D, Bottasso O, Dominino JC, et al. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Respir Med 1999;93:557-62.
39. Chedid L, Audibert F, Lefrancier P, Choay J, Lederer E. Modulation of the immune response by a synthetic adjuvant and analogs. Proc Natl Acad Sci USA 1976; 73:2472-5.
40. Standford JL, Grange JM. New concepts for the control of tuberculosis in the twenty first century. J R Coll Phy 1993;27:218-23.
41. Ravn P, Boesen P, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 1997; 158:1949-55.
42. Tuli SM. Preliminary observations of the effect of immuno-modulation in multi-drug resistant cases of osteo-articular tuberculosis. Ind J Orthop 1999;33:83-5.